What is it about?
Delivery of therapeutics into the brain across the Blood-Brain barrier (BBB) is a key challenge for the treatment of brain disorders. The main goal of this research was to find nanoparticles that would be ideal for crossing the BBB, for future therapeutic applications, and would allow tracking their location within the brain, using CT imaging.
Featured Image
Read the Original
This page is a summary of: The Effect of Nanoparticle Size on the Ability to Cross the Blood–Brain Barrier: An
In Vivo
Study, Nanomedicine, June 2017, Taylor & Francis,
DOI: 10.2217/nnm-2017-0022.
You can read the full text:
Contributors
The following have contributed to this page







